Rating History for MapLight Therapeutics (MPLT) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/27/2026 | Sean Laaman | Downgrade | Equalweight (Overweight) |
21.00 (34.00) |
34.00 (13.31) |
-60.85% | Details |
 |
|||||||
|
|||||||
